99mTc-HFaPSMA

N/A

Report date: 2025/11/28 17:54:24

Base Information

Drug Name99mTc-HFaPSMA

Drug Alias Name99mTc-HFaPSMA

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionPositron-emission tomography enhancersProstate-Specific Membrane Antigen bindersFibroblast activation protein alpha binders

TargetsProstate-Specific Membrane AntigenProlyl endopeptidase FAP

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesPeking University Xi'An Jiaotong University

China Registration ClassN/A

Develop Information

Active CompaniesPeking University

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A